Amedisys Inc (AMED) Social Stream
AMEDISYS INC (AMED) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering AMEDISYS INC.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
---|---|---|---|---|---|---|
2021-11-09 | 13 | $235 | $150 | $204.666 | $93.55 | 118.78% |
2021-12-07 | 13 | $235 | $150 | $205.5 | $93.55 | 119.67% |
2021-12-21 | 14 | $235 | $150 | $206.076 | $93.55 | 120.28% |
2022-01-06 | 14 | $230 | $150 | $203.384 | $93.55 | 117.41% |
2022-01-20 | 14 | $230 | $150 | $202.23 | $93.55 | 116.17% |
2022-02-01 | 14 | $230 | $145 | $199.461 | $93.55 | 113.21% |
2022-02-02 | 14 | $230 | $145 | $199.692 | $93.55 | 113.46% |
2022-02-17 | 14 | $230 | $147 | $197.923 | $93.55 | 111.57% |
2022-02-25 | 15 | $230 | $147 | $195.928 | $93.55 | 109.44% |
2022-03-01 | 15 | $230 | $147 | $190.357 | $93.55 | 103.48% |
2022-03-08 | 15 | $230 | $147 | $191.642 | $93.55 | 104.86% |
2022-03-24 | 15 | $230 | $160 | $192.714 | $93.55 | 106% |
2022-04-01 | 15 | $230 | $162 | $194.142 | $93.55 | 107.53% |
2022-04-29 | 15 | $230 | $131 | $190.785 | $93.55 | 103.94% |
2022-05-03 | 15 | $221 | $131 | $185.857 | $93.55 | 98.67% |
2022-05-26 | 15 | $221 | $131 | $183.357 | $93.55 | 96% |
2022-05-27 | 15 | $221 | $117 | $182.357 | $93.55 | 94.93% |
2022-06-13 | 15 | $221 | $117 | $179.357 | $93.55 | 91.72% |
2022-06-21 | 15 | $221 | $107 | $178.642 | $93.55 | 90.96% |
2022-07-14 | 16 | $221 | $102 | $164.733 | $93.55 | 76.09% |
2022-07-29 | 16 | $221 | $102 | $160.133 | $93.55 | 71.17% |
2022-08-01 | 16 | $200 | $102 | $154.866 | $93.55 | 65.54% |
2022-08-02 | 16 | $200 | $102 | $152.2 | $93.55 | 62.69% |
2022-08-03 | 16 | $200 | $95 | $146.533 | $93.55 | 56.64% |
2022-09-06 | 16 | $200 | $95 | $147.133 | $93.55 | 57.28% |
2022-09-19 | 16 | $200 | $95 | $147.933 | $93.55 | 58.13% |
2022-10-03 | 16 | $200 | $95 | $145.933 | $93.55 | 55.99% |
2022-10-05 | 16 | $200 | $95 | $145.266 | $93.55 | 55.28% |
2022-10-19 | 16 | $190 | $95 | $141.933 | $93.55 | 51.72% |
2022-10-25 | 16 | $190 | $95 | $141.266 | $93.55 | 51.01% |
2022-10-27 | 16 | $190 | $90 | $140.466 | $93.55 | 50.15% |
2022-10-28 | 16 | $190 | $90 | $135.933 | $93.55 | 45.31% |
2022-11-02 | 16 | $190 | $90 | $127.733 | $93.55 | 36.54% |
2022-11-03 | 16 | $190 | $90 | $125.785 | $93.55 | 34.46% |
2022-11-11 | 16 | $190 | $90 | $124.785 | $93.55 | 33.39% |
2022-12-05 | 16 | $190 | $90 | $122.642 | $93.55 | 31.1% |
2023-01-03 | 16 | $190 | $84 | $122.214 | $93.55 | 30.64% |
2023-01-17 | 16 | $190 | $84 | $121.428 | $93.55 | 29.8% |
2023-01-19 | 16 | $190 | $84 | $120 | $93.55 | 28.27% |
2023-02-15 | 16 | $190 | $84 | $118.142 | $93.55 | 26.29% |
2023-02-21 | 16 | $190 | $84 | $118.928 | $93.55 | 27.13% |
2023-02-22 | 16 | $190 | $84 | $116.571 | $93.55 | 24.61% |
2023-02-24 | 16 | $190 | $84 | $116 | $93.55 | 24% |
2023-03-10 | 15 | $130 | $84 | $110.923 | $93.55 | 18.57% |
2023-03-29 | 15 | $130 | $84 | $108.384 | $93.55 | 15.86% |
2023-04-13 | 15 | $130 | $84 | $107.23 | $93.55 | 14.62% |
2023-04-21 | 16 | $130 | $84 | $105.785 | $93.55 | 13.08% |
2023-05-05 | 14 | $120 | $84 | $99.416 | $93.55 | 6.27% |
2023-05-09 | 14 | $125 | $81 | $98 | $93.55 | 4.76% |
2023-06-06 | 14 | $120 | $81 | $96.5 | $93.55 | 3.15% |
2023-06-26 | 13 | $115 | $84 | $96.75 | $93.55 | 3.42% |
2023-06-27 | 13 | $115 | $84 | $98.166 | $93.55 | 4.93% |
2023-07-03 | 13 | $115 | $84 | $99 | $93.55 | 5.83% |
2023-07-28 | 13 | $115 | $84 | $99.25 | $93.55 | 6.09% |
2023-07-31 | 13 | $115 | $84 | $100.666 | $93.55 | 7.61% |
2023-08-01 | 13 | $115 | $84 | $101 | $93.55 | 7.96% |
2023-08-02 | 13 | $115 | $84 | $101.545 | $93.55 | 8.55% |
2023-08-21 | 12 | $115 | $84 | $101.545 | $93.55 | 8.55% |
2023-09-13 | 12 | $115 | $84 | $100.272 | $93.55 | 7.19% |
2023-09-20 | 13 | $115 | $73 | $98.083 | $93.55 | 4.85% |
The Trend in the Analyst Price Target
AMED's average price target has moved down $85.27 over the prior 16 months.
Over the past 50 weeks, AMED's average upside potential has been 21.52%.
Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
---|---|---|---|---|---|---|
2022-10-05 | 16 | 200 | 95 | 145.266 | 99.75 | 45.63% |
2022-10-25 | 16 | 190 | 95 | 141.266 | 101.91 | 38.62% |
2023-07-03 | 13 | 115 | 84 | 99.000 | 91.35 | 8.37% |
2023-09-01 | 12 | 115 | 84 | 100.272 | 93.85 | 6.84% |
2023-09-15 | 13 | 115 | 73 | 98.083 | 93.73 | 4.64% |
AMED Broker Recommendations Summary
Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
---|---|---|---|---|---|---|
2.77 | 2 | 1 | 9 | 1 | 1 | 13 |
The Trend in the Broker Recommendations
Over the past 26 weeks, AMED's average broker recommendation rating worsened by 0.25.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for AMED as an investment opportunity.
- AMED has a greater number of analysts covering the stock than 6621.21% of stocks in the mid market cap category.
- In the context of stocks in the mid market cap category, AMEDISYS INC's average analyst price target is higher than 6453.63% of them.
- To contextualize these metrics, consider that out of Healthcare stocks, AMEDISYS INC's upside potential (average analyst target price relative to current price) is greater than 2513.38% of them.
- AMED has a lower variance in analysts' estimates than -3496.28% of Healthcare stocks.
Stocks similar to AMEDISYS INC in the Healthcare industry regarding analyst recommendations and price targets are CHE, SEM, and MD.
View All Top Stocks by Price Target
Make investment decisions regarding AMED using the data that counts. Try POWR Ratings for free.